Human NF1-mutant melanomas have the worst outcome among all metastatic melanomas [8], and PTEN-mutant melanomas are known to be resistant to T-cell mediated immunotherapy such as the immune checkpoint inhibitor [25]. The gene discussed is NF1; the disease is metastatic melanoma.